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The aim of this study was to develop a real time polymerase chain reaction (PCR) for quantitative 
detection of Streptococcus pneumoniae from clinical respiratory specimens. Initially, 184 respiratory 
specimens from patients with community acquired pneumonia (CAP) (n = 129) and 55 cases with 
hospital associated pneumonia (HAP) were bacteriologically investigated. To check the colonization 
status among the healthy individuals, 32 preschool and 31 adults were screened in parallel. All 
specimens were cultured on selective culture media to isolate S. pneumoniae, Legionella spp. and 
Mycoplasma spp. A 166 bp fragment corresponding to cbp A gene of S. pneumoniae was amplified from 
clinical specimens using Taqman probe real time PCR. Culture showed 14, but real time PCR showed 15 
specimens as being positive for S. pneumoniae. The specificity and sensitivity of real time PCR was 
99.14% and 100 respectively. Co-infections of S. pneumoniae with Legionella pneumophila, 
Chlamydophila pneumoniae, Mycoplasma pneumoniae and Staphylococcus aureus were observed in 5 
cases (35.72%). S. pneumoniae was counted <103 cfu/ml from the co-infected cases. Using real time 
PCR, a cutoff of 103cfu/ml is introduced to differentiate colonization from infection in respiratory tract. 
This is the first report on the prevalence CAP with S. pneumoniae in Iran (12.40%).  
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INTRODUCTION  
 
Pneumoniae is one of the major causes of mortalities 
throughout the world. Streptococcus pneumoniae is an 
important and common pathogen that is isolated from 
patients (30 to 40%) with community acquired pneumonia 
(CAP) (Morozumi et al., 2006). It can also cause 
bacteremia, meningitis, otitis media and sinusitis among 
young children and adults (Klugman et  al.,  2008).  Rapid 
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diagnostic methods with high specificity and sensitivity is 
highly demanded to manage the patients and reduce the 
mortality. Based on clinical finding and blood culture, the 
Thorax Associations in the USA and the UK have 
introduced guidelines for diagnosis (WHO /UNICEF, 
2009; Mandell, 2007; British Thoracic Society Reports, 
2009). However, rapid detection has important role in 
saving life of patients with severe pneumonia 
(WHO/UNICEF, 2009; Mandell, 2007; British Thoracic 
Society Reports, 2009). 
The chest radiography showing alveolar consolidation 
and   blood   culture   are   usually  used  to  define  acute  
  
 
 
respiratory infections (McAvin et al., 2001). This method, 
however, can not show consolidation in the onset of 
pneumonia particularly in children and lack the sensitivity 
in vaccinated patients (Klugman et al., 2008). 
 The Thoracic Associations suggested clinical finding to 
be confirmed by microbiologic semi quantitative culture 
(Mandell et al., 2007; British Thoracic Society Reports, 
2009). Culture of nasopharyngeal swab and sputum (or 
any samples) can be performed for this purpose. Since S. 
pneumoniae can be isolated from 5 to 40% of healthy 
children and 20 to 30% of adult, controversy remains 
over its colonization and infection since antibiotic 
suppression may give false negative result in culture. 
Moreover, contamination with normal microbiota such as 
alpha streptococci makes decision of administration of 
antibiotic, particularly to the young children, difficult too 
(McAvin et al., 2001). Detection of organism from the 
blood is considered as “gold standard” (British Thoracic 
Society Reports, 2009; Rudan et al., 2004), but it is labor 
and time consuming. Moreover, bacteremia caused by S. 
pneumoniae occurs in less than 30% of patients with 
CAP (Greiner et al., 2001). 
Using real time polymerase chain reaction (PCR), the 
virulence factors of S. pneumoniae such as ply gene 
(pneumolysin), Spn9802, lytA gene (autolysin) and wzy 
gene (capsular gene) have been searched by several 
investigators (Carvalho et al., 2007). Yang et al. (2005) 
used ply for identification of this organism from sputum 
specimens with sensitivity and specificity of 90 and 80%, 
respectively (Yang et al., 2005).  
Autolysin is a well characterized virulence factor 
encoded by the lytA gene. The lytA is conserved within 
species and has been used as a sensitive and specific 
marker for identification of S. pneumoniae strains 
(McAvin et al., 2001). Another gene, Spn9802, was used 
on the nasopharyngeal aspirates and reported to 
correlate with disease symptoms (Abdeldaim et al., 
2008). These genes were also seen in some strain of S. 
mitis-oralis group (Whatmore et al., 2000).Although, 
almost clinical isolates are encapsulated and the wzy 
gene (capsular gene) for species specific detection had 
been used, isolates of S. pneumoniae lacking capsule 
has recently been reported (Abdeldaim et al., 2008; 
Bergmann and Hammerschmidt, 2006).  
We developed real time PCR by amplification of cbpA 
gene to directly detect and quantify the S. pneumoniae 
from the nasopharyngeal swabs and sputum specimens 
collected from patients with CAP as well as healthy 
children and adults. 
 Using this method, we introduced a cutoff for differen-
tiation of colonization from infection. Due to self-
medication in Iran, it is difficult to determine the true 
prevalence of S. pneumoniae in CAP patient by con-
ventional bacteriological techniques. Therefore, this is the 
first report on the role of S. pneumoniae in CAP among 
the Iranian patients and its presence with microbiota in 
healthy individuals. 
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MATERIALS AND METHODS 
 
Study population  
 
This is a cross-sectional study on a cohort of Iranian patients with 
CAP referred to teaching Hospitals (Imam Khomaini, Rasol-
Akaram, Labafinezhad and Shahid Rajaee) and 3 private hospitals 
[Mehrad, Kasraand Shahriar Hospital) in Tehran. The inclusion 
criteria for the patients with suspected pneumonia were: 
consolidation in chest X-ray, fever (>38°C), leukocytosis (>104 /µL) 
and respiratory rate ≥ 32 breath per min. Community acquired 
pneumonia was defined according to the ATS and BTS 
guidelines(Mandell, 2007; British Thoracic Society Reports, 2009). 
Exclusion criteria were antibiotic consumption in less than 96 h 
later. 
Overall, 459 patients referred to the aforementioned hospitals 
were monitored and 129 cases with CAP were included in this 
study. The nasopharyngeal swabs were used to collect samples 
from the randomly selected healthy individual including 32 
preschool children (mean age 4.7± 0.3 years) with less than 6 years 
old and 16 young persons (Mean 28.4 ± 2.04) and 15 old people 
(mean age 58.9 ± 3.2) range 55 to 69 years old. Also, 55 patients 
with hospital associated pneumonia staying in intensive or critical 
care units (ICU or CCU) more than 48 h were subjected to S. 
pneumoniae primers and probes for monitoring S. pneumoniae in 
HAP patients. 
 
 
Culture and identification 
 
Nasopharyngeal swab of sputum from all patients with suspected 
pneumonia and bronco alveolar lavage (BAL) from HAP patients 
were cultured. The swabbed specimens were held on tubes 
containing 2 ml of 0.85% NaCl and vortex for 30 s. They were 
subsequently cultured on sheep blood agar, gentamicin blood agar 
and thioglycholate broth using calibrated loop (0.01 µL). The 
cultures were incubated in 3 to 5% CO2 at 35 ± 1°C. The samples 
and clinical specimens were also cultured on buffered charcoal 
yeast extract (BCYE-GVPC) to screen them for Legionella spp. 
after heat treatment. In addition, samples were cultured in glucose 
methylene blue diphasic media for possible growth of Mycoplasma 
spp. They were also checked for Chlamydiophila pneumoniae using 
a commercial PCR diagnostic kit from Primer design, UK 
(http://primerdesign.co.uk/Pathogen_Detection_Kits.asp). 
Before culturing, direct smears from specimens were prepared 
and microscopically checked after staining with Gram method. The 
samples were qualified as clinically significant in case the numbers 
of WBC were 10 cells per field of microscope at high power. 
Moreover, identification of S. pneumoniae was based on colony 
morphology, alpha hemolytic on sRBC blood agar, catalase 
negative, optochin susceptibility and bile solubility (Murray and 
Baron, 2007). The identification was also confirmed by capsular 
polyclonal serum agglutination test (Bahar Co.Tehran-Iran). Sheep 
blood agar plates were lawn with suspected S. pneumoniae 
morphology and an optochin disk (Hi-media, India) was placed in 
the center of each plate. Optochin susceptibility was defined after 
incubation for 18 to 24 h at 35°C in both 5% CO2 and ambient air 
environments with ≥ 14 mm inhibition zone as positive (Bergmann 
and HammerSchmidt, 2006). After the growth, the colonies were 
counted in duplicate. Based on the Colony forming unit (CFUs) per 
milliliter, the culture count reporting for the physicians were 1,000 - 
10,000 - 50,000 and 100,000. 
 
 
DNA extraction 
 
DNA was extracted using enzyme digestion and phenol chloroform 
method   as  described  previously  (Feizabadi  et  al.,  2010).  Five- 
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Figure 1. The region of cbpA gene in S. pneumoniae D39 (NC_008533.1).the amplification region was marked by 
red arrow. 
 
 
 
microliter aliquots of extracted DNA solution were used as template 
in real time PCR assay (Feizabadi et al., 2010). The concentration 
and purity of extracted DNA were assessed at wavelengths 260 to 
280 nm using Nanodrop (Labnet - USA). 
 
 
Standards, sensitivity and specificity  
 
S. pneumoniae (NTCC 11109) and human DNA were used as 
positive and negative controls, respectively. Serial dilutions of 
overnight culture of S. pneumoniae containing 108 to 102 CFU /ml 
were prepared in 0.85% NaCl for drawing standard curve and to 
determine the sensitivity of real time PCR by comparing standard 
tube to turbidity of 0.5 McFarland (approximate count 1.5×108 
CFU/ml bacteria) and using spectrophotometer (Eppendorf, 
Hamburg, Germany) (Feizabadi et al., 2010).  
When the result of turbidity of the tube and colony count was SD 
<1%, it was considered as standard tube of count. DNA was 
extracted from 200 µL of every dilution tube as earlier described 
(Feizabadi et al., 2010).  
The concentration of extracted DNA was measured using a 
Nanodrop (Analytik Jena -Germany) and by using mathematical 
equation, it was converted to bacterial count based on standard S. 
pneumoniae genome.Bacterial DNA from Pseudomonas 
aeruginosa (ATCC 49189) Stenotrophomonas maltophilia 
(NTCC10257), Klebsiella pneumoniae (NTCC 5056), Escherichia 
coli (NTCC 21157), Staphylococcus aureus (ATCC 29213), 
Streptococcus oralis (NTCC 57342 ), Streptococcus mitis (NTCC 
58274), Legionella pneumophila (NTCC 11192), Mycoplasma 
pneumoniae (NTCC 10119) and human DNA were used as 
negative controls in real time PCR. Beta actin gene (primer and 
probe) was used as internal control with every sample to detect 
PCR inhibitor as recommended (Pfaffl, 2001). 
The human white blood cell DNA was used as negative control in  
this study since our primers and probe do not react with human 
genome and positive for beta actin gene to evaluate PCR 
performance. The specificity of the developed real time PCR was 
then assessed using the aforementioned standard bacterial strains, 
as well as the specimens that were positive for other 
microorganisms. For plotting standard curve, real time PCR assays 
were performed in duplicate. 
 
 
Primer design 
 
The conserved sequence from cbpA (choline binding protein A) was 
selected as a target for real time PCR. The primers: cbp A-F: 
CTTCCAAGCTCATCCCTGAA (20bp); cbpA-R: CTTTCACAT 
CGGACTCAGCA (20bp); and Taqman probe (cbpA-P): FAM-
GAGAAGAAGGTTGAAGAAGCTGA-BHQ1 (23bp), were designed 
for real time PCR assay using the strategy earlier explained 
(Feizabadi et al., 2010). The expected size of amplicon is 166 bp 
(Figure 1). 
 
 
Real time PCR 
 
Amplification and detection were performed in Line gene K (Bioer 
Technology Co., Ltd. - China). The reactions consisted of 0.2 µM of 
each primer and probe, 0.2 µM dNTP, 1.5 µM MgCl2, 1.1 U of DNA 
polymerase (mi Taq- Metabion, Martinsried, Germany), 2.5 µL of 10 
x PCR buffer, and 5 µL of the template DNA in total volume of 25 
µL with double distilled water. The cycling program was adjusted at 
95°C for 10 min and then 35 cycles of 10 s each at 95°C 
(denaturation) followed by 50 s at 60°C with fluorescent collection 
(annealing and extension). Every sample was run in triplicate and 
mean of them was reported. The efficacy of PCR (E) was calculated 
using the slope of standard curve in the equation: E = [10 (-1/slope)] -1   
Nomanpour et al.         12829 
 
 
 
Table 1. Distribution and clinical findings of study groups.  
 
Patient CAP (%) Healthy control HAP Preschool adult 
No. 129 32 31 55 
Age 12 - 71 3.5 - 6 25-69 14 - 73 
Background disease 47 (36.44) 0 0 55 
Chest X-Ray infiltration 108 (83.7) ND ND 55 
Leukocytosis 113 (87.60) ND ND 49 
Fever (≥38.0) 103 (79.84) 0 0 50 
ESR(≥4.0 first hour) 99 (76.75) 0 0 35 
Antibiotic consumption 16 (12.40) 0 0 55 
Cough 129 (100) 0 0 54 
Chest pain 126 (97.68) 0 0 55 
 
Preschool and adults are control group; ND, not determined; ESR, erythrocyte sediment rate. 
 
 
 
as described by Pfaffl (2001). 
 
 
Statistical analysis 
 
Comparisons of culture and real time PCR was done by using 
Cohen´s Kappa test. The SPSS 13.0 software program was used 
for Chi-square and confidence interval analysis of the data (Alonzo 
and Pepe, 1999). 
 
 
RESULTS 
 
Study group 
 
All cases with CAP were diagnosed by pulmonary 
specialist, among them 108 cases had consolidation in 
chest X-ray and 19 showed infiltrations one week later. 
Overall, 25 of CAP patients died because of pneumonia. 
Antibiotic was consumed by 16 of patients < 12 hour prior 
to sampling. Distribution of study group and demographic 
feature is shown in the Table 1. 
 
 
Culture semi-quantity and real time PCR  
 
Out of 129 CAP specimens, real time PCR detected 16 
positive for S. pneumonia CbpA gene (prevalence 
12.40%). The culture was positive for 14 specimens, 
confirming the results of real time PCR. Semi 
quantification culture was in the range of 500 to 105 cfu 
per milliliter (Table 2). The result of culture for a 78 years 
old diabetic patient (sputum IM26) was negative at the 
time of admission in hospital. This patient however, died 
after one week with pneumonia complication. More also, 
S. pneumoniae from the specimens of 3 children in 
preschool control group (Nb2, Nb17 and Nb31) and 2 
adults yielded growths. The organism was also detected 
by real time PCR from their specimens. Two of control 
group (Nb6 and Na18) had alpha hemolytic Streptococci 
with susceptibility to optochin in their specimens. The 
isolated organisms from these patients bacteriologically 
were not identified as S. pneumoniae and gave no 
amplicons in real time PCR too.  
The bacterial loads in the clinical specimens and the 
controls, determined by culture and real time PCR, are 
shown in Table 2. L. pneumophila (two patients), S. 
aureus, M. pneumonia and C. pneumoniae (each one 
case) were also isolated from 5 of patients with S. 
pneumoniae culture positive (35.71% of positives). Since 
the load of these bacteria was > 10,000 cfu/ml of 
specimens, they may be presumed as the main 
pathogens. These patients were under treatment with 
azithromycin and showed good response to therapy. 
Standard curve of triplicated every dilution had slope -
3.29 ± 0.1 and R2 >0.993 with SD < 0.01. Efficacy of PCR 
test was 101.34% (E=10 (-1/slope) - 1) (Feizabadi et al., 
2010). Results of real time PCR and quantification of 
every sample are shown in Table 2. Based on the results 
of culture, as golden standard, the specificity and 
sensitivity of real time PCR were 99.14 and 100% 
respectively. Negative predictive values of the test were 
100%. Amplification of target genes from S. pneumoniae 
in serial dilutions ranged from 109 to 102 CFU /ml and 
showed that the technique can detect every calculated 
tube count with SD <1%. The results were confirmed in 
triplicate. There was agreement between the results of 
culture and real time PCR (Cohen´s Kappa value ≈1.0, 
SD <0.001 with p <0.001). 
 
 
DISCUSSION 
 
Annually, 1.8 million children deaths occur due to 
pneumonia throughout the world (Whatmore et al., 2000; 
CDC/MMWR, 2010; Rudan et al., 2008). In respect to 
importance of pneumonia, WHO designated 12th 
November, 2010 as World Pneumonia Day (CDC/ 
MMWR,   2010).   In    spite    of   progress   in  diagnostic 
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Table 2. Identification and Quantification of culture and real time PCR result. 
 
ID Optochin 
susceptibility 
Bile 
solubility 
Capsular 
agglutination 
Culture 
(cfu/ml) 
Real time PCR cbp 
A (cfu/ml) (mean) Co-infection 
IM3 + + + <105 1.27 e + 5  
IM26 ND ND ND NG 2.84 e + 2 L. pneumophila 
IM53 + + + <104 1.11 e + 4  
IM59 + + + <5×104 3.0 e + 4  
IM63 + + + >1000 2.1 e + 3 S. aureus 
M78 + + + <5×104 4.01 e + 4  
M84 + + - <103 8.64 e + 2 L. pneumophila 
B12 + - - NG 0 E. faecalis 
B27 + + + >105 3.56 e + 6  
B43 + + + >104 5.01 e + 4  
Ks17 + + + >105 7.19 e + 7  
Ks25 + + + >105 3.34 e + 6  
E59 + + + <103 9.87 e + 2 C. pneumoniae 
L31 + + + >105 1.56 e + 6  
L19 ND ND ND NG 6.09 e + 1  
L20 + + + <5×104 1.53 e + 5  
S46 + + + <500 2.39 e + 2 M. pneumoniae 
Nb2 + + + <500 2.3 e + 2  
Nb6 + - - <103 0 (alpha Strep) 
Nb17 + + + < 500 5.13 e + 2  
Nb31 + + + <500 8,36 e + 2  
Na18 +* - - >103 0 (alpha Strep) 
Na23 + + + <500 1.78 e + 2  
Na27 + + + 103 9.03 e + 2  
 
* The inhibition zone was less than 14 mm. 
 
 
 
microbiology, difficulties in detection and differentiation of 
colonization and infection remain to be resolved. 
Presumptive identification of S. pneumoniae in diagnostic 
laboratory is based on phonotypic characteristics 
including colonial morphology, alpha hemolytic activity, 
optochin sensitivity, bile solubility and agglutination with 
anti-pneumococcal capsular polyclonal antibodies 
(Bergmann and Hammerschmidt, 2006). But recently, 
optochin resistance and bile insolubility have been 
reported for S. pneumoniae (Whatmore et al., 2000; 
Carvalho, et al., 2010). These atypical characteristic 
make the identification ambiguous if nasopharyngeal, 
sputum and other specimens are contaminated with 
closely related species present in the normal flora such 
as S. mitis and S. oralis. These normal flora 16S rRNA 
gene sequences show more than 90% similarities with S. 
pneumonia (Whatmore et al., 2000).  
To overcome these problems, various real time PCR 
methods had been introduced for detecting and quantify-
ing S. pneumoniae by amplification of pneumococcal 
virulence factors genes including autolysin (lyt A) (Harris 
et al., 2008; Loens et al., 2009; Brugger et al., 2009), 
pneumolysin (ply) (Greiner et al., 2001; Moscoso et al., 
2006) and pneumococcal surface adhesion (psa A) 
(Carvalho et al., 2007). However, there are several 
reports stating that lyt A, ply and psa A are not specific to 
S. pneumoniae and may be shared by some strains of 
S.mitis –S.oralis groups (Carvalho et al., 2007; Moscoso 
et al., 2009). This study was therefore designed to 
develop a novel cbpA based real time PCR assay to 
detect S. pneumoniae from patients and healthy control 
specimens. cbpA encodes choline binding protein which 
is a multifunctional pneumococcal surface protein. This 
protein mediates colonization of pneumococci into 
nasopharyngeal epithelial cells and invasion of the host 
cells (a major adhesin). It also interacts with components 
of the immune system (Carvalho et al., 2007) and play 
important roles in pneumococcal infections (Moscoso et 
al., 2006; Moscoso et al., 2009). The 3′ end region of 
cbpA was selected for designing the Oligonucleotides 
after aligning this gene with cbp A-like genes (Figure 1). 
The specificity of cbp A primers and probe was proved in 
challenge with standard Gram positive and Gram 
negative strains. In comparison with culture, this new 
assay showed sensitivity of 100% and specificity of 
99.14%. It can detect and enumerate S. pneumoniae 
from clinical specimens in < 4 h and can help to make 
quick and correct decision for treatment in clinical wards. 
  
 
 
The number of S. pneumoniae in sample had 
concordance with semi-quantitative culture (p<0.001). 
The specificities of real time PCR using lyt A, ply and psa 
A (up to 96%) are reported to be lower than our result 
(99.14%). However, all of them had similar sensitivity 
(100%) (McAvin et al., 2001; Greiner et al., 2001; 
Carvalho et al., 2007; Yang et al., 2005; Harris et al., 
2008). Our real time PCR may be useful not only for 
monitoring of patients but also for differentiation of 
colonization from infection. The clinical findings and 
cumulative scoring clinical signs (such as CURE 65) in 
less than 90% of our cases confirmed pneumonia. 
Despite of great values of clinical findings in diagnosis of 
pneumonia, the infective agent should be identified to 
implement appropriate antibiotic therapy policy (Mandell 
et al., 2007; British Thoracic Society Reports, 2009). In 
respect to labor and time consuming of culture method 
for detection and identification S. pneumonia from clinical 
specimens, we suggest that real time PCR is the best 
substitute, since it was proved as a rapid and accurate 
diagnostic tool in this study.  
In our study, we assessed 63 healthy persons as 
controls. In preschool group, only 9.38% of children gave 
positive results in real time PCR assay and culture. The 
adult group gave 6.45% positive results in the same 
experiments. The bacterial load calculated by real time 
PCR and culture in both groups was <1000 cfu/ml. In 
patients with bacterial load <1000 cfu /ml, other bacteria 
were involved as the main cause of pneumonia. 
Exception was patient IM63, who was co-infected with S. 
aureus (load 2.1e + 3 cfu/ml). Therefore, S. pneumoniae 
with 1000 cfu/ml load may be considered as cutoff for 
colonization. It is the first time to introduce a cutoff for S. 
pneumoniae in Iran. However it needs to be evaluated on 
larger population.S. pneumoniae is the most common 
pathogen of pneumonia in all range of age (Al-Qadi et al., 
2010) and responsible for more than 40% of community 
acquired pneumonia (CDC /MMWR, 2010). In our study, 
the prevalence of S. pneumoniae in patients with CAP 
was 12.40%, which is lower than other countries in the 
Middle East and Asian countries (Rudan et al., 2008; Al-
Ghizawi et al., 2007; Arifeen et al., 2009; Köksal et al., 
2010). Agwu et al. (2006) reported incidence of S. 
pneumoniae in CAP patient referred to tuberculosis clinic 
(Nigeria) as 6.4% (Agwu et al., 2006). However, in a recent 
study from Turkey, S. pneumoniae was isolated from (14.7%) of 
CAP patients (Köksal et al., 2010). Rudan et al. (2008) also 
reported a prevalence of 9.6 % for CAP with S. pneumoniae in 
Kuwait, which is not significantly different from our study (P= 
0.01). Self-antibiotic consumption in Iran may be a reason for 
lower isolation and prevalence than other countries. This 
self-medication may also possibly be a reason for lower 
prevalence of S pneumoniae among pneumoniae among 
healthy individuals in Iran(9.38 and 6.45%) compared 
with reports from other countries (up to 40% of children 
and 10 to 20% adults) (Rudan et al., 2004, 2008). 
In this study, we entered 55 bronchoalveolar lavage 
(BAL)  specimens  from  hospital  associated  pneumonia  
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(HAP) that were hospitalized in Shahid Rajee Heart 
center admitted for heart failure disease and surgery. 
Culture was positive only in one patient, while real time 
PCR had detected S. pneumoniae in two patients. 
Hence, real time PCR of cbp A can be used directly for 
detection of S. pneumoniae from various clinical 
specimens including sputum, nasopharyngeal swab and 
BAL to monitor CAP, HAP and colonization in healthy 
individuals. We therefore recommend the evaluation of 
this test as multiplex real time PCR for atypical causative 
agent of CAP. 
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